Please provide your email address to receive an email when new articles are posted on . The etanercept biosimilar, LBEC0101, demonstrated equivalent clinical efficacy and comparable safety profile to ...
Once weekly ENBREL significantly reduced rheumatoid arthritis pain, inflammation & improved function
THOUSAND OAKS, Calif., and COLLEGEVILLE, Pa., June 19, 2003 - Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced that patients receiving ENBREL(R) ...
Eight months after bowing to FDA pressure to pull the original spot, Amgen has launched a revamped television ad for Enbrel (etanercept) that it says better explains the product’s psoriasis indication ...
THOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., June 13, 2007 -- Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced the presentation of additional data that ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio A reduced dose of Enbrel in addition to ...
A patent fight has already delayed Sandoz' biosimilar version of Amgen's anti-inflammatory blockbuster Enbrel. And now, it looks as if Sandoz will have to wait a little longer for a clear shot at the ...
Inadequate Initial Response is the Top Reason Why Rheumatologists Move Patients from Simponi and Cimzia, According to a New Report from Decision Resources BURLINGTON, Mass., Dec. 7, 2010 /PRNewswire/ ...
An appeals court ruling means biosimilar competition won't affect U.S. Enbrel sales for a long time. Enbrel is a tumor necrosis factor (TNF) inhibitor that earned its first FDA approval all the way ...
THOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., Feb. 4, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) and Pfizer Inc. (NYSE: PFE) today announced results from a new trial that demonstrated Enbrel® ...
WASHINGTON — Colorado is pioneering a new way for states to crack down on prescription drug costs. In a first-in-the-nation move, a state board voted to create a payment limit for a widely prescribed ...
When Pfizer’s US Enbrel sales force gives way to Amgen’s in July, reps risk layoff if they don’t get picked up by Amgen or re-assigned to Pfizer’s new JAK inhibitor. The news that Pfizer was turning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results